1. Home
  2. DBVT vs AII Comparison

DBVT vs AII Comparison

Compare DBVT & AII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DBVT
  • AII
  • Stock Information
  • Founded
  • DBVT 2002
  • AII 2006
  • Country
  • DBVT France
  • AII United States
  • Employees
  • DBVT N/A
  • AII N/A
  • Industry
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • AII Property-Casualty Insurers
  • Sector
  • DBVT Health Care
  • AII Finance
  • Exchange
  • DBVT Nasdaq
  • AII Nasdaq
  • Market Cap
  • DBVT 464.0M
  • AII 452.1M
  • IPO Year
  • DBVT N/A
  • AII 2025
  • Fundamental
  • Price
  • DBVT $15.55
  • AII $23.75
  • Analyst Decision
  • DBVT Buy
  • AII Buy
  • Analyst Count
  • DBVT 4
  • AII 6
  • Target Price
  • DBVT $14.81
  • AII $25.20
  • AVG Volume (30 Days)
  • DBVT 203.8K
  • AII 90.8K
  • Earning Date
  • DBVT 10-28-2025
  • AII 11-11-2025
  • Dividend Yield
  • DBVT N/A
  • AII N/A
  • EPS Growth
  • DBVT N/A
  • AII N/A
  • EPS
  • DBVT N/A
  • AII 3.87
  • Revenue
  • DBVT $3,800,000.00
  • AII $260,047,000.00
  • Revenue This Year
  • DBVT $1,743.46
  • AII $25.82
  • Revenue Next Year
  • DBVT $1,044.34
  • AII $25.65
  • P/E Ratio
  • DBVT N/A
  • AII $6.14
  • Revenue Growth
  • DBVT N/A
  • AII 1.73
  • 52 Week Low
  • DBVT $2.21
  • AII $15.78
  • 52 Week High
  • DBVT $18.00
  • AII $24.72
  • Technical
  • Relative Strength Index (RSI)
  • DBVT 60.41
  • AII N/A
  • Support Level
  • DBVT $14.85
  • AII N/A
  • Resistance Level
  • DBVT $16.95
  • AII N/A
  • Average True Range (ATR)
  • DBVT 1.14
  • AII 0.00
  • MACD
  • DBVT -0.18
  • AII 0.00
  • Stochastic Oscillator
  • DBVT 28.24
  • AII 0.00

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

About AII American Integrity Insurance Group Inc. Common Stock

American Integrity Insurance Group Inc is engaged in the property and casualty insurance business. It provides personal residential property insurance for single-family homeowners and condominium owners as well as coverage for vacant dwellings and investment properties, predominantly in Florida. The Company's property and casualty insurance is currently offered in Florida, South Carolina, and Georgia.

Share on Social Networks: